Global Neurological Disorder Drugs Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2023

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Jun-2018   |    Format :PDF   |    Number of Pages : 103
This report studies the global Neurological Disorder Drugs market status and forecast, categorizes the global Neurological Disorder Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global Neurological Disorder Drugs market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report
    Novartis AG
    GlaxoSmithKline plc
    Merck & Co.
    Bayer AG
    AstraZeneca
    Boehringer Ingelheim GmbH
    Teva Pharmaceutical Industries Ltd.
    ...

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
    North America
    Europe
    China
    Japan
    India
    Southeast Asia
    Other regions (Central & South America, Middle East & Africa)

The regional scope of the study is as follows:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antipsychotic
    Hypnotic & Sedative
    Analgesics
    Anticoagulants
    Others

By Application, the market can be split into
    Hospital
    Clinic
    Home

The study objectives of this report are:
    To analyze and study the global Neurological Disorder Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
    Focuses on the key Neurological Disorder Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Neurological Disorder Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Neurological Disorder Drugs Manufacturers
Neurological Disorder Drugs Distributors/Traders/Wholesalers
Neurological Disorder Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Neurological Disorder Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Global Neurological Disorder Drugs Market Professional Survey Report 2018
1 Industry Overview of Neurological Disorder Drugs
    1.1 Definition and Specifications of Neurological Disorder Drugs
        1.1.1 Definition of Neurological Disorder Drugs
        1.1.2 Specifications of Neurological Disorder Drugs
    1.2 Classification of Neurological Disorder Drugs
        1.2.1 Antipsychotic
        1.2.2 Hypnotic & Sedative
        1.2.3 Analgesics
        1.2.4 Anticoagulants
        1.2.5 Others
    1.3 Applications of Neurological Disorder Drugs
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Home
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 Europe
        1.4.3 China
        1.4.4 Japan
        1.4.5 Southeast Asia
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Neurological Disorder Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Neurological Disorder Drugs
    2.3 Manufacturing Process Analysis of Neurological Disorder Drugs
    2.4 Industry Chain Structure of Neurological Disorder Drugs

3 Technical Data and Manufacturing Plants Analysis of Neurological Disorder Drugs
    3.1 Capacity and Commercial Production Date of Global Neurological Disorder Drugs Major Manufacturers in 2017
    3.2 Manufacturing Plants Distribution of Global Neurological Disorder Drugs Major Manufacturers in 2017
    3.3 R&D Status and Technology Source of Global Neurological Disorder Drugs Major Manufacturers in 2017
    3.4 Raw Materials Sources Analysis of Global Neurological Disorder Drugs Major Manufacturers in 2017

4 Global Neurological Disorder Drugs Overall Market Overview
    4.1 2013-2018E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2013-2018E Global Neurological Disorder Drugs Capacity and Growth Rate Analysis
        4.2.2 2017 Neurological Disorder Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2013-2018E Global Neurological Disorder Drugs Sales and Growth Rate Analysis
        4.3.2 2017 Neurological Disorder Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2013-2018E Global Neurological Disorder Drugs Sales Price
        4.4.2 2017 Neurological Disorder Drugs Sales Price Analysis (Company Segment)

5 Neurological Disorder Drugs Regional Market Analysis
    5.1 North America Neurological Disorder Drugs Market Analysis
        5.1.1 North America Neurological Disorder Drugs Market Overview
        5.1.2 North America 2013-2018E Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2013-2018E Neurological Disorder Drugs Sales Price Analysis
        5.1.4 North America 2017 Neurological Disorder Drugs Market Share Analysis
    5.2 Europe Neurological Disorder Drugs Market Analysis
        5.2.1 Europe Neurological Disorder Drugs Market Overview
        5.2.2 Europe 2013-2018E Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 Europe 2013-2018E Neurological Disorder Drugs Sales Price Analysis
        5.2.4 Europe 2017 Neurological Disorder Drugs Market Share Analysis
    5.3 China Neurological Disorder Drugs Market Analysis
        5.3.1 China Neurological Disorder Drugs Market Overview
        5.3.2 China 2013-2018E Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 China 2013-2018E Neurological Disorder Drugs Sales Price Analysis
        5.3.4 China 2017 Neurological Disorder Drugs Market Share Analysis
    5.4 Japan Neurological Disorder Drugs Market Analysis
        5.4.1 Japan Neurological Disorder Drugs Market Overview
        5.4.2 Japan 2013-2018E Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Japan 2013-2018E Neurological Disorder Drugs Sales Price Analysis
        5.4.4 Japan 2017 Neurological Disorder Drugs Market Share Analysis
    5.5 Southeast Asia Neurological Disorder Drugs Market Analysis
        5.5.1 Southeast Asia Neurological Disorder Drugs Market Overview
        5.5.2 Southeast Asia 2013-2018E Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Southeast Asia 2013-2018E Neurological Disorder Drugs Sales Price Analysis
        5.5.4 Southeast Asia 2017 Neurological Disorder Drugs Market Share Analysis
    5.6 India Neurological Disorder Drugs Market Analysis
        5.6.1 India Neurological Disorder Drugs Market Overview
        5.6.2 India 2013-2018E Neurological Disorder Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2013-2018E Neurological Disorder Drugs Sales Price Analysis
        5.6.4 India 2017 Neurological Disorder Drugs Market Share Analysis

6 Global 2013-2018E Neurological Disorder Drugs Segment Market Analysis (by Type)
    6.1 Global 2013-2018E Neurological Disorder Drugs Sales by Type
    6.2 Different Types of Neurological Disorder Drugs Product Interview Price Analysis
    6.3 Different Types of Neurological Disorder Drugs Product Driving Factors Analysis
        6.3.1 Antipsychotic of Neurological Disorder Drugs Growth Driving Factor Analysis
        6.3.2 Hypnotic & Sedative of Neurological Disorder Drugs Growth Driving Factor Analysis
        6.3.3 Analgesics of Neurological Disorder Drugs Growth Driving Factor Analysis
        6.3.4 Anticoagulants of Neurological Disorder Drugs Growth Driving Factor Analysis
        6.3.5 Others of Neurological Disorder Drugs Growth Driving Factor Analysis

7 Global 2013-2018E Neurological Disorder Drugs Segment Market Analysis (by Application)
    7.1 Global 2013-2018E Neurological Disorder Drugs Consumption by Application
    7.2 Different Application of Neurological Disorder Drugs Product Interview Price Analysis
    7.3 Different Application of Neurological Disorder Drugs Product Driving Factors Analysis
        7.3.1 Hospital of Neurological Disorder Drugs Growth Driving Factor Analysis
        7.3.2 Clinic of Neurological Disorder Drugs Growth Driving Factor Analysis
        7.3.3 Home of Neurological Disorder Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Neurological Disorder Drugs
    8.1 Novartis AG
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Novartis AG 2017 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Novartis AG 2017 Neurological Disorder Drugs Business Region Distribution Analysis
    8.2 GlaxoSmithKline plc
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 GlaxoSmithKline plc 2017 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 GlaxoSmithKline plc 2017 Neurological Disorder Drugs Business Region Distribution Analysis
    8.3 Merck & Co.
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Merck & Co. 2017 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Merck & Co. 2017 Neurological Disorder Drugs Business Region Distribution Analysis
    8.4 Bayer AG
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Bayer AG 2017 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Bayer AG 2017 Neurological Disorder Drugs Business Region Distribution Analysis
    8.5 AstraZeneca
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 AstraZeneca 2017 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 AstraZeneca 2017 Neurological Disorder Drugs Business Region Distribution Analysis
    8.6 Boehringer Ingelheim GmbH
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Boehringer Ingelheim GmbH 2017 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Boehringer Ingelheim GmbH 2017 Neurological Disorder Drugs Business Region Distribution Analysis
    8.7 Teva Pharmaceutical Industries Ltd.
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Teva Pharmaceutical Industries Ltd. 2017 Neurological Disorder Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Teva Pharmaceutical Industries Ltd. 2017 Neurological Disorder Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of Neurological Disorder Drugs Market
    9.1 Global Neurological Disorder Drugs Market Trend Analysis
        9.1.1 Global 2018-2025 Neurological Disorder Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2018-2025 Neurological Disorder Drugs Sales Price Forecast
    9.2 Neurological Disorder Drugs Regional Market Trend
        9.2.1 North America 2018-2025 Neurological Disorder Drugs Consumption Forecast
        9.2.2 Europe 2018-2025 Neurological Disorder Drugs Consumption Forecast
        9.2.3 China 2018-2025 Neurological Disorder Drugs Consumption Forecast
        9.2.4 Japan 2018-2025 Neurological Disorder Drugs Consumption Forecast
        9.2.5 Southeast Asia 2018-2025 Neurological Disorder Drugs Consumption Forecast
        9.2.6 India 2018-2025 Neurological Disorder Drugs Consumption Forecast
    9.3 Neurological Disorder Drugs Market Trend (Product Type)
    9.4 Neurological Disorder Drugs Market Trend (Application)

10 Neurological Disorder Drugs Marketing Type Analysis
    10.1 Neurological Disorder Drugs Regional Marketing Type Analysis
    10.2 Neurological Disorder Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Neurological Disorder Drugs by Region
    10.4 Neurological Disorder Drugs Supply Chain Analysis

11 Consumers Analysis of Neurological Disorder Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Neurological Disorder Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures
    Figure Picture of Neurological Disorder Drugs
    Table Product Specifications of Neurological Disorder Drugs
    Table Classification of Neurological Disorder Drugs
    Figure Global Production Market Share of Neurological Disorder Drugs by Type in 2017
    Figure Antipsychotic Picture
    Table Major Manufacturers of Antipsychotic
    Figure Hypnotic & Sedative Picture
    Table Major Manufacturers of Hypnotic & Sedative
    Figure Analgesics Picture
    Table Major Manufacturers of Analgesics
    Figure Anticoagulants Picture
    Table Major Manufacturers of Anticoagulants
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Neurological Disorder Drugs
    Figure Global Consumption Volume Market Share of Neurological Disorder Drugs by Application in 2017
    Figure Hospital Examples
    Table Major Consumers in Hospital
    Figure Clinic Examples
    Table Major Consumers in Clinic
    Figure Home Examples
    Table Major Consumers in Home
    Figure Market Share of Neurological Disorder Drugs by Regions
    Figure North America Neurological Disorder Drugs Market Size (Million USD) (2013-2025)
    Figure Europe Neurological Disorder Drugs Market Size (Million USD) (2013-2025)
    Figure China Neurological Disorder Drugs Market Size (Million USD) (2013-2025)
    Figure Japan Neurological Disorder Drugs Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Neurological Disorder Drugs Market Size (Million USD) (2013-2025)
    Figure India Neurological Disorder Drugs Market Size (Million USD) (2013-2025)
    Table Neurological Disorder Drugs Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Neurological Disorder Drugs in 2017
    Figure Manufacturing Process Analysis of Neurological Disorder Drugs
    Figure Industry Chain Structure of Neurological Disorder Drugs
    Table Capacity and Commercial Production Date of Global Neurological Disorder Drugs Major Manufacturers in 2017
    Table Manufacturing Plants Distribution of Global Neurological Disorder Drugs Major Manufacturers in 2017
    Table R&D Status and Technology Source of Global Neurological Disorder Drugs Major Manufacturers in 2017
    Table Raw Materials Sources Analysis of Global Neurological Disorder Drugs Major Manufacturers in 2017
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Neurological Disorder Drugs 2013-2018E
    Figure Global 2013-2018E Neurological Disorder Drugs Market Size (Volume) and Growth Rate
    Figure Global 2013-2018E Neurological Disorder Drugs Market Size (Value) and Growth Rate
    Table 2013-2018E Global Neurological Disorder Drugs Capacity and Growth Rate
    Table 2017 Global Neurological Disorder Drugs Capacity (K Pcs) List (Company Segment)
    Table 2013-2018E Global Neurological Disorder Drugs Sales (K Pcs) and Growth Rate
    Table 2017 Global Neurological Disorder Drugs Sales (K Pcs) List (Company Segment)
    Table 2013-2018E Global Neurological Disorder Drugs Sales Price (USD/Pcs)
    Table 2017 Global Neurological Disorder Drugs Sales Price (USD/Pcs) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Pcs) of Neurological Disorder Drugs 2013-2018E 
    Figure North America 2013-2018E Neurological Disorder Drugs Sales Price (USD/Pcs)
    Figure North America 2017 Neurological Disorder Drugs Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Pcs) of Neurological Disorder Drugs 2013-2018E 
    Figure Europe 2013-2018E Neurological Disorder Drugs Sales Price (USD/Pcs) 
    Figure Europe 2017 Neurological Disorder Drugs Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Pcs) of Neurological Disorder Drugs 2013-2018E
    Figure China 2013-2018E Neurological Disorder Drugs Sales Price (USD/Pcs)
    Figure China 2017 Neurological Disorder Drugs Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Pcs) of Neurological Disorder Drugs 2013-2018E
    Figure Japan 2013-2018E Neurological Disorder Drugs Sales Price (USD/Pcs)
    Figure Japan 2017 Neurological Disorder Drugs Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Neurological Disorder Drugs 2013-2018E
    Figure Southeast Asia 2013-2018E Neurological Disorder Drugs Sales Price (USD/Pcs)
    Figure Southeast Asia 2017 Neurological Disorder Drugs Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Pcs) of Neurological Disorder Drugs 2013-2018E
    Figure India 2013-2018E Neurological Disorder Drugs Sales Price (USD/Pcs)
    Figure India 2017 Neurological Disorder Drugs Sales Market Share
    Table Global 2013-2018E Neurological Disorder Drugs Sales (K Pcs) by Type
    Table Different Types Neurological Disorder Drugs Product Interview Price
    Table Global 2013-2018E Neurological Disorder Drugs Sales (K Pcs) by Application
    Table Different Application Neurological Disorder Drugs Product Interview Price
    Table Novartis AG Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Novartis AG Neurological Disorder Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2017 Novartis AG Neurological Disorder Drugs Business Region Distribution
    Table GlaxoSmithKline plc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 GlaxoSmithKline plc Neurological Disorder Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2017 GlaxoSmithKline plc Neurological Disorder Drugs Business Region Distribution
    Table Merck & Co. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Merck & Co. Neurological Disorder Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2017 Merck & Co. Neurological Disorder Drugs Business Region Distribution
    Table Bayer AG Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Bayer AG Neurological Disorder Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2017 Bayer AG Neurological Disorder Drugs Business Region Distribution
    Table AstraZeneca Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 AstraZeneca Neurological Disorder Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2017 AstraZeneca Neurological Disorder Drugs Business Region Distribution
    Table Boehringer Ingelheim GmbH Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Boehringer Ingelheim GmbH Neurological Disorder Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2017 Boehringer Ingelheim GmbH Neurological Disorder Drugs Business Region Distribution
    Table Teva Pharmaceutical Industries Ltd. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
    Figure 2017 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Business Region Distribution
    Figure Global 2018-2025 Neurological Disorder Drugs Market Size (K Pcs) and Growth Rate Forecast
    Figure Global 2018-2025 Neurological Disorder Drugs Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2018-2025 Neurological Disorder Drugs Sales Price (USD/Pcs) Forecast
    Figure North America 2018-2025 Neurological Disorder Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure China 2018-2025 Neurological Disorder Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Europe 2018-2025 Neurological Disorder Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Southeast Asia 2018-2025 Neurological Disorder Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure Japan 2018-2025 Neurological Disorder Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
    Figure India 2018-2025 Neurological Disorder Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
    Table Global Sales Volume (K Pcs) of Neurological Disorder Drugs by Type 2018-2025
    Table Global Consumption Volume (K Pcs) of Neurological Disorder Drugs by Application 2018-2025
    Table Traders or Distributors with Contact Information of Neurological Disorder Drugs by Region



Latest News

15-Jan-2019 | Medical Care

Health Insurance Market In China Witnessing A Huge Boom Over High Premium Plan Demand

Medicare has outpaced life insurance policies in China as the fastest-growing category of the industry as wealthy consumers try to fill the insufficient public coverage. The emergence of health ins ...

14-Jan-2019 | Electrical & Electronic Device

Growing Collaboration For Futuristic Product Development To Lead Pharmaceutical Market Growth

C-LEcta, a global technology leader in enzyme technology and bioprocess development for controlled markets such as the food and pharmaceutical industry, has inked two duration cooperation agreement ...

03-Dec-2018 | Technology

Don’t await a 5G iPhone on or before 2020

Apple’s timeline for adopting the next generation of cellular connectivity, 5G, by suggesting the first compatible iPhone won’t come before 2020. Earlier rumors and reports pointed to t ...

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...